Kamal Narang: SRA to Extend Development Work for CDC-FDA Vaccine Info Database

Kamal Narang
Kamal Narang

SRA International has been awarded a potential five-year, $18 million contract to help develop and maintain applications and process data for a vaccine information system used by the Centers for Disease Control and Prevention and the Food and Drug Administration.

The company will also carry out medical coding, clinical research, information technology and outreach efforts for the Vaccine Adverse Event Reporting System,  SRA said Monday.

VAERS contains reports submitted by vaccine makers, providers and recipients on the potential side affects of vaccines after they are administered to people.

Kamal Narang, vice president of SRA’s health group, said the company aims to support “the government in responding to the challenges created by newly licensed vaccines, evolving vaccination schedules, and emergency immunization campaigns.”

SRA has supported the VAERS system since 1999, he said.

The CDC, FDA use VAERS to detect new, unusual or rare adverse affects of vaccines and track trends related to those affects.

VAERS also is built to help users identify potential risk factors to patients, identify vaccine lots that have significant numbers or types of reported affects and assess safety of newly-licensed vaccines.

Video of the Day

GovCon Wire Logo

Sign Up Now! GovCon Wire provides you with Daily Updates and News Briefings about Contract Awards

Related Articles

The Ultimate Guide to Winning Government Contracts Let us show you how top executives are winning so you can replicate it